Skip to content
Other

Effect of exchange rate changes on cash, cash equivalents and restricted cash

Biogen Effect of exchange rate changes on cash, cash equivalents and restricted cash decreased by 126.4% to -$18M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 152.5%, from $34.3M to -$18M.

Analysis

StatementIncome Statement
SectionOther
First reportedQ3 2021
Last reportedQ1 2026Apr 29, 2026
Metric ID: other_effect_of_exchange_rate_on_cash_cash_equivalents_r_71d71e

Historical Data

12 periods
 Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q1 '26
Value-$25.4M-$9.4M-$61.2M-$52.3M$20M-$28.7M-$23.1M-$12.6M$42.4M$34.3M$68.3M-$18M
QoQ Change+63.0%-551.1%+14.5%+138.2%-243.5%+19.5%+45.5%+436.5%-19.1%+99.1%-126.4%
YoY Change-105.9%+312.8%+45.1%-215.5%+247.7%+248.5%+642.1%-152.5%
Range-$61.2M$68.3M
CAGR-11.8%
Avg YoY Growth+127.8%
Median YoY Growth+146.4%

Effect of exchange rate changes on cash, cash equivalents and restricted cash at Other Companies

Frequently Asked Questions

What is Biogen's effect of exchange rate changes on cash, cash equivalents and restricted cash?
Biogen (BIIB) reported effect of exchange rate changes on cash, cash equivalents and restricted cash of -$18M in Q1 2026.
How has Biogen's effect of exchange rate changes on cash, cash equivalents and restricted cash changed year-over-year?
Biogen's effect of exchange rate changes on cash, cash equivalents and restricted cash decreased by 152.5% year-over-year, from $34.3M to -$18M.